首页 > 市场调查报告书 > 材料

包装/容器医药品包装

市场调查报告书

商品编码

1474068

全球合约药品包装市场 - 2024-2031

Global Contract Pharmaceutical Packaging Market - 2024-2031

出版日期: 2024年05月02日 | 出版商:

DataM Intelligence | 英文 193 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

全球合约药品包装市场在 2023 年达到 59 亿美元，预计到 2031 年将达到 105 亿美元，2024-2031 年预测期间复合年增长率为 7.5%。

在全球经济成长、人口老化和人口成长以及新产品推出的推动下，全球製药业正在呈指数级增长。根据 IQVIA 的数据，2020 年全球医药市场收入为 12,652 亿美元，并且正在稳步扩张。许多药品供应商明白，将商业和临床包装外包给製药承包商可以提高收入，因此业务中的合约包装正在扩大。

近年来，美国食品药物管理局批准的新药数量大幅增加。例如，美国食品药物管理局表示，CDER 2020 年批准了 53 种创新药物，高于前一年的 48 种。此外，仿製药计划今年还授权或有条件批准了 948 个仿製药申请。 FDA 批准更多创新药物对市场产生了积极影响。

到2023年，欧洲预计将占据全球合约药品包装市场的约1/4。欧盟法规要求所有製药公司如果想在欧盟销售药品，就必须遵循欧盟良好生产规范。 2021年1月，诺华对给药新创公司Credence MedSystems进行策略性投资。这项投资旨在帮助推进 Credence 药物输送系统的开发和可扩展性。

动力学

对注射药品的需求不断增加

对注射药物不断增长的需求正在加速玻璃瓶在製药业的扩张。癌症和其他高效药物（例如抗体偶联物、类固醇和快速起效的静脉输液）的健康市场预计将成为主要成长动力。此外，糖尿病患者人数的增加也大大促进了注射药物玻璃瓶的成长。

根据世界卫生组织的数据，全球有超过 4.22 亿人患有糖尿病。这一数字的变化增加了对青霉素的需求，促进了市场成长。此外，生物製品的成长预计将对区域市场产生重大影响。例如，2021 年 4 月，康泰伦特完成了 1,400 万美元的扩建，以提高其印第安纳州布鲁明顿工厂的生物製品包装能力。

包装技术进步

包装机械和材料的技术进步有助于塑造全球合约药品包装市场。这些发展是由自动化、材料科学和永续性创新所驱动的，预计将开闢巨大的市场潜在机会。自动化包装操作是技术创新的重要组成部分。

现代包装技术包括先进的机器人系统、电子控制和即时监控功能。它可以提高包装过程中的精度、效率并减少人为错误。例如，2020年6月，PCI Pharma宣布与Experic达成合作协议，共同研究临床和商业製造、包装和供应链服务，以实现双方的共同成长。

永续性和替代问题

由于生活方式趋势和文化发展的不断发展，消费者的口味可能会发生变化，从而影响合约药品包装的需求。由于市场渗透率高且客户偏好成熟，工业化国家的合约药品包装业务已趋于饱和。製造商可能会发现很难使他们的产品与众不同并在饱和的市场中竞争，导致定价压力和利润率下降。

消费者选择这些替代品是因为其移动性、隔热性和便利性等优点，从而减少了对传统陶瓷或玻璃合约药品包装的需求。对环境永续性的日益关注促使消费者寻找传统合约药品包装的环保替代品。因此，人们需要可回收和可生物降解的选择，这对依赖非永续类型的生产者提出了挑战。

The global pharmaceutical sector is expanding at an exponential rate, propelled by global economic growth, an aging and growing population and new product introductions. According to IQVIA, the globally pharmaceutical market's revenue in 2020 was US$ 1,265.2 billion and is expanding steadily. Many pharmaceutical vendors understood that outsourcing commercial and clinical packaging to a pharmaceutical contractor boost earnings, hence the contract packaging in the business is expanding.

The number of new pharmaceuticals approved by U.S. Food and Drug Administration has increased significantly in recent years. For example, the Food and Drug Administration said that CDER approved 53 innovative medications in 2020, up from 48 the previous year. Additionally, the generic medication program authorized or conditionally approved 948 generic medicine applications this year. The market has been positively impacted by the FDA's approval of more innovative medications.

In 2023, Europe is expected to be hold about 1/4th of the global contract pharmaceutical packaging market. EU regulations require all pharmaceutical firms to follow EU Good Manufacturing Practices if they want to sell their medicines in the EU. In January 2021, Novartis made a strategic investment in drug delivery startup Credence MedSystems. The investment is intended to help advance the development and scalability of Credence's drug delivery systems.

Dynamics

Increasing Demand for Injectable Pharmaceuticals

The growing demand for injectable medications is accelerating the expansion of glass bottles in the pharmaceutical industry. The healthy market for cancer and other high-potency medications (such as antibody conjugates, steroids and IV fluids with a rapid beginning of action) is expected to be the primary growth driver. Furthermore, the growing number of diabetics contributes significantly to the growth of glass bottles for injectable medications.

In accordance with the World Health Organization, over 422 million people globally have diabetes. Changes in this figure enhance demand for penicillin, contributing to market growth. Furthermore, the growth of biologics is anticipated to have a substantial impact on the regional market. For example, in April 2021, Catalent completed a US$ 14 million expansion to increase biologics packaging capacity at its Bloomington, Indiana facility.

Technological Advancements in Packaging

Technological improvements in packaging machinery and materials have helped to shape the globally contract pharmaceutical packaging market. The developments, driven by innovations in automation, materials science and sustainability, are expected to open up significant market potential opportunities. Automating packing operations is an important component of technological innovation.

Modern packaging technology includes advanced robotic systems, electronic controls and real-time monitoring capabilities. It translates into increased precision, efficiency and fewer human errors in the packing process. For example, in June 2020, PCI Pharma announced a cooperation deal with Experic to investigate clinical and commercial manufacturing, packaging and supply chain services, resulting in collective growth for both parties.

Sustainability and Alternative Concerns

Consumer tastes may shift due to growing lifestyle trends and cultural developments, affecting contract pharmaceutical packaging demand. Owing to the high market penetration and mature client preferences, the contract pharmaceutical packaging business in industrialized countries has become saturated. Manufacturers may find it difficult to differentiate their products and compete in saturated markets, resulting in pricing pressures and decreased profit margins.

Consumers choose these alternatives because of benefits such as mobility, insulation and convenience, which reduces demand for traditional ceramic or glass contract pharmaceutical packaging. Growing concerns about environmental sustainability have driven consumers to look for eco-friendly alternatives to traditional contract pharmaceutical packagings. As a result, there is a desire for recyclable and biodegradable options, which poses a challenge to producers who rely on non-sustainable types.

Segment Analysis

The global contract pharmaceutical packaging market is segmented based on type, raw material, application and region.

Lightweigth and Not Prone to Breakage Drives the Segment Growth

Plastics & polymer is expected to be the dominant segment with over 30% of the market during the forecast period 2024-2031. Plastic bottle filling will be expected to increase rapidly over the projection period due to its several benefits, including its light weight, which saves space and transportation, as well as freight costs. Unlike medications contained in glass bottles, plastic bottles are less likely to break and contribute to the necessary cost savings associated with glass bottles.

For example, Aphena Pharma Solutions, a pharmaceutical contract packaging company, said in January 2021 that it had built ten high-speed bottling lines, leveraging a US$ 21 million investment in solid dose contract packaging. The company also wants to add 30 more high-speed lines in its newly purchased 500,000 sq ft facility, increasing the monthly capacity to over 80 million bottles to target the pharmaceutical solid dose packaging market.

Geographical Penetration

Rising Investments in Pharmaceutical Sector in North America

North America is the dominant region in the global contract pharmaceutical packaging market covering more than 35% of the market. The presence of multiple pharmaceutical contract packaging service providers in the region increased the overall market size. Many contract packaging companies have made investments in extending their facilities and customer base, as well as increasing their geographical footprint, through acquisitions and collaborations.

In September 2020, Essentra Packaging revealed the acquisition of a 3C! Packaging, a North Carolina-based company that designs and manufactures cartons, literature, labels and packaging for the pharmaceutical sector. Such acquisitions allow companies like Essentra Packaging to strengthen their position in the pharmaceutical packaging industry and create prospects for growth in the pharmaceutical manufacturing hub in North America.

Competitive Landscape

The major global players in the market include Catalent Pharma Solutions, Aphena Pharma Solutions, ROPACK INC, Wasdell Packaging Group, Baxter BioPharma Solutions, AbbVie Contract Manufacturing, Pfizer CentreSource, Daito Pharmaceutical, Nipro Corporation and Becton Dickinson & Company.

COVID-19 Impact Analysis

The pandemic caused an increase in demand for pharmaceutical products such as vaccinations, drugs and medical equipment to battle the spread of COVID-19 and treat affected people. The rising demand for pharmaceuticals necessitated the use of contract packaging services to assure the timely packaging and distribution of important medicines. Regulatory authorities introduced temporary regulatory flexibilities and expedited approval processes to support the development, manufacturing and distribution of COVID-19 vaccines and treatments.

Contract packaging facilities took steps to guarantee staff safety and well-being while continuing operations during the pandemic. To reduce the danger of COVID-19 transmission, it includes creating remote labor arrangements, increased hygiene controls and social distancing measures within production facilities.

Russia-Ukraine War Impact

Russia and Ukraine are both major actors in the global pharmaceutical supply chain, supplying raw materials, active pharmaceutical ingredients and packaging materials to pharmaceutical producers globally. Any supply chain disruptions caused by the conflict, like transportation disruptions, export prohibitions or trade restrictions, may have an impact on the availability and pricing of pharmaceutical packaging materials.

The dispute interrupts the manufacture and export of vital pharmaceutical packaging materials such as polymers, plastics, glass vials and aluminum foils, causing global shortages and price instability. Contract packaging companies may experience difficulty in procuring necessary packaging materials, affecting their capacity to execute orders and meet the demand of pharmaceutical clients.

By Type

Primary Packaging System
Secondary Packaging System
Tertiary Packaging System

By Raw Material

Plastic & Polymers
Glass
Metals
Paper & Board
Rubber
Cotton
Others

By Application

Transmucosal Drug Delivery Packaging
Pulmonary Drug Delivery Packaging
Nasal Drug Delivery Packaging
Topical Drug Delivery Packaging
Injectable Packaging
Oral Drug Delivery Packaging
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In December 2022, Nelipak Corporation constructed a cutting-edge flexible packaging production facility in Winston-Salem, North Carolina. The strategic initiative will expand Nelipak's healthcare packaging capabilities across Europe to the Americas, catering to the region's growing need.
In October 2022, Aphena Pharma Solutions Inc. reported that its US$ 20 million expansion and renovation, which began in mid-2019 in Cookeville, Tennessee, has now completed, providing a considerable amount of available solid dose packaging capacity.
In October 2020, Alnylam Pharmaceuticals collaborated with Sharp to package its authorized RNAi therapeutic medicines for European markets. Sharp's Hamont-Achel facility in Belgium is going to handle the packaging for Alnylam's offerings throughout Europe. The agreement represented a significant foreign investment for Alnylam in Belgium, identifying with their objective to strengthen their presence in the region and establish it as a vital hub for operations.

Why Purchase the Report?

To visualize the global contract pharmaceutical packaging market segmentation based on type, raw material, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of contract pharmaceutical packaging market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global contract pharmaceutical packaging market report would provide approximately 62 tables, 61 figures and 193 pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet by Type
3.2.Snippet by Raw Material
3.3.Snippet by Application
3.4.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.Increasing Demand for Injectable Pharmaceuticals
  - 4.1.1.2.Technological Advancements in Packaging
- 4.1.2.Restraints
  - 4.1.2.1.Sustainability and Alternative Concerns
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis
5.5.Russia-Ukraine War Impact Analysis
5.6.DMI Opinion

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID-19
- 6.1.2.Scenario During COVID-19
- 6.1.3.Scenario Post COVID-19
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Type

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2.Market Attractiveness Index, By Type
7.2.Primary Packaging System*
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3.Secondary Packaging System
7.4.Tertiary Packaging System

8.By Raw Material

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 8.1.2.Market Attractiveness Index, By Raw Material
8.2.Plastic & Polymers*
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Glass
8.4.Metals
8.5.Paper & Board
8.6.Rubber
8.7.Cotton
8.8.Others

9.By Application

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2.Market Attractiveness Index, By Application
9.2.Transmucosal Drug Delivery Packaging*
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Pulmonary Drug Delivery Packaging
9.4.Nasal Drug Delivery Packaging
9.5.Topical Drug Delivery Packaging
9.6.Injectable Packaging
9.7.Oral Drug Delivery Packaging
9.8.Others

10.By Region

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2.Market Attractiveness Index, By Region
10.2.North America
- 10.2.1.Introduction
- 10.2.2.Key Region-Specific Dynamics
- 10.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1.U.S.
  - 10.2.6.2.Canada
  - 10.2.6.3.Mexico
10.3.Europe
- 10.3.1.Introduction
- 10.3.2.Key Region-Specific Dynamics
- 10.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1.Germany
  - 10.3.6.2.UK
  - 10.3.6.3.France
  - 10.3.6.4.Italy
  - 10.3.6.5.Russia
  - 10.3.6.6.Rest of Europe
10.4.South America
- 10.4.1.Introduction
- 10.4.2.Key Region-Specific Dynamics
- 10.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1.Brazil
  - 10.4.6.2.Argentina
  - 10.4.6.3.Rest of South America
10.5.Asia-Pacific
- 10.5.1.Introduction
- 10.5.2.Key Region-Specific Dynamics
- 10.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1.China
  - 10.5.6.2.India
  - 10.5.6.3.Japan
  - 10.5.6.4.Australia
  - 10.5.6.5.Rest of Asia-Pacific
10.6.Middle East and Africa
- 10.6.1.Introduction
- 10.6.2.Key Region-Specific Dynamics
- 10.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11.Competitive Landscape

11.1.Competitive Scenario
11.2.Market Positioning/Share Analysis
11.3.Mergers and Acquisitions Analysis

12.Company Profiles

12.1.Catalent Pharma Solutions*
- 12.1.1.Company Overview
- 12.1.2.Product Portfolio and Description
- 12.1.3.Financial Overview
- 12.1.4.Key Developments
12.2.Aphena Pharma Solutions
12.3.ROPACK INC
12.4.Wasdell Packaging Group
12.5.Baxter BioPharma Solutions
12.6.AbbVie Contract Manufacturing
12.7.Pfizer CentreSource
12.8.Daito Pharmaceutical
12.9.Nipro Corporation
12.10.Becton Dickinson & Company

LIST NOT EXHAUSTIVE